Correlation Between Genomma Lab and Alfa SAB

Can any of the company-specific risk be diversified away by investing in both Genomma Lab and Alfa SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genomma Lab and Alfa SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genomma Lab Internacional and Alfa SAB de, you can compare the effects of market volatilities on Genomma Lab and Alfa SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genomma Lab with a short position of Alfa SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genomma Lab and Alfa SAB.

Diversification Opportunities for Genomma Lab and Alfa SAB

0.35

Correlation Coefficient

Genomma Lab  Alfa SAB

Weak diversification

The 3 months correlation between Genomma and Alfa is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Genomma Lab Internacional and Alfa SAB de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alfa SAB de and Genomma Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genomma Lab Internacional are associated (or correlated) with Alfa SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alfa SAB de has no effect on the direction of Genomma Lab i.e., Genomma Lab and Alfa SAB go up and down completely randomly.

Pair Corralation between Genomma Lab and Alfa SAB

Assuming the 90 days trading horizon Genomma Lab Internacional is expected to under-perform the Alfa SAB. In addition to that, Genomma Lab is 1.01 times more volatile than Alfa SAB de. It trades about -0.08 of its total potential returns per unit of risk. Alfa SAB de is currently generating about 0.04 per unit of volatility. If you would invest  1,532  in Alfa SAB de on October 13, 2024 and sell it today you would earn a total of  13.00  from holding Alfa SAB de or generate 0.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Genomma Lab Internacional  vs.  Alfa SAB de

Genomma Lab Internacional

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genomma Lab Internacional are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Genomma Lab may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Alfa SAB de

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Alfa SAB de are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy primary indicators, Alfa SAB is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Genomma Lab and Alfa SAB

The main advantage of trading using opposite Genomma Lab and Alfa SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genomma Lab position performs unexpectedly, Alfa SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alfa SAB will offset losses from the drop in Alfa SAB's long position.

The idea behind Genomma Lab Internacional and Alfa SAB de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.